Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
6.42
+0.02 (0.31%)
Nov 13, 2026, 4:00 PM EST - Market closed
Lifecore Biomedical Revenue
Lifecore Biomedical had revenue of $25.32M in the quarter ending September 30, 2026, a decrease of -18.60%. This brings the company's total for the last twelve months to $119.13M, down -8.58% year-over-year. In the fiscal year ending May 25, 2025, Lifecore Biomedical had annual revenue of $128.87M with 0.47% growth. That makes Lifecore Biomedical the 22,211th largest company in the world by revenue and 3,249th in the United States.
Revenue (ttm)
$119.13M
Revenue Growth
-8.58%
P/S Ratio
2.28
Revenue / Employee
$278,693
Employees
382
Market Cap
243.36M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 25, 2025 | 128.87M | 606.00K | 0.47% |
| May 26, 2024 | 128.26M | 24.99M | 24.20% |
| May 28, 2023 | 103.27M | -8.00M | -7.19% |
| May 29, 2022 | 111.27M | 10.40M | 10.31% |
| May 30, 2021 | 100.87M | -59.19M | -36.98% |
| May 31, 2020 | 160.07M | -397.49M | -71.29% |
| May 26, 2019 | 557.56M | 33.33M | 6.36% |
| May 27, 2018 | 524.23M | 54.45M | 11.59% |
| May 28, 2017 | 469.78M | -7.14M | -1.50% |
| May 29, 2016 | 476.92M | -62.34M | -11.56% |
| May 31, 2015 | 539.26M | 62.44M | 13.10% |
| May 25, 2014 | 476.81M | 35.11M | 7.95% |
| May 26, 2013 | 441.71M | 124.16M | 39.10% |
| May 27, 2012 | 317.55M | 40.82M | 14.75% |
| May 29, 2011 | 276.73M | 44.64M | 19.23% |
| May 30, 2010 | 232.09M | 3.54M | 1.55% |
| May 31, 2009 | 228.55M | -2.64M | -1.14% |
| May 25, 2008 | 231.19M | 25.76M | 12.54% |
| May 27, 2007 | 205.43M | -23.70M | -10.34% |
| May 28, 2006 | 229.13M | 24.41M | 11.92% |
| May 29, 2005 | 204.72M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Tilray Brands | 963.10M |
| Emergent BioSolutions | 649.10M |
| Evolus | 325.47M |
| Aurora Cannabis | 221.16M |
| Canopy Growth | 217.18M |
| Akebia Therapeutics | 197.20M |
| Kamada | 196.87M |
| Anika Therapeutics | 123.43M |
LFCR News
- 14 hours ago - Lifecore Biomedical Proxy statement: Proxy filing - Filings
- 2 days ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: ADT Inc. (NYSE – ADT), RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR) - GlobeNewsWire
- 8 days ago - Lifecore Biomedical Proxy statement: Proxy filing - Filings
- 9 days ago - Lifecore reports Q3 EPS ($1.08), consensus (30c) - TheFly
- 9 days ago - Lifecore Biomedical Reports Financial Results for the Third Quarter Ended September 30, 2026, and Provides Corporate Update - GlobeNewsWire
- 9 days ago - Lifecore Biomedical Quarterly report: Q1 2027 - Filings
- 9 days ago - Lifecore Biomedical Earnings release: Q1 2027 - Filings
- 14 days ago - Lifecore Biomedical Proxy statement: Proxy filing - Filings